495 related articles for article (PubMed ID: 7977880)
1. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
[TBL] [Abstract][Full Text] [Related]
2. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
5. Predictors of response to clozapine.
Lieberman JA; Kane JM; Safferman AZ; Pollack S; Howard A; Szymanski S; Masiar SJ; Kronig MH; Cooper T; Novacenko H
J Clin Psychiatry; 1994 Sep; 55 Suppl B():126-8. PubMed ID: 7961556
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.
Umbricht DS; Wirshing WC; Wirshing DA; McMeniman M; Schooler NR; Marder SR; Kane JM
J Clin Psychiatry; 2002 May; 63(5):420-4. PubMed ID: 12019667
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clozapine response in schizophrenia.
Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
[TBL] [Abstract][Full Text] [Related]
10. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
12. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
13. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
14. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
17. Clozapine, negative symptoms, and extrapyramidal side effects.
Kane JM; Safferman AZ; Pollack S; Johns C; Szymanski S; Kronig M; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():74-7. PubMed ID: 7961579
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
Kane JM
Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
[TBL] [Abstract][Full Text] [Related]
19. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
[TBL] [Abstract][Full Text] [Related]
20. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
Still DJ; Dorson PG; Crismon ML; Pousson C
Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
